ProfileGDS4459 / ENSG00000163517
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 24% 26% 27% 19% 21% 15% 21% 24% 23% 22% 19% 23% 24% 14% 20% 11% 12% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.5424
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.6626
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.3727
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.4619
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.1521
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9615
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.0621
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.2524
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.1323
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.1922
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.1419
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.1423
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.2824
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.1414
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.9620
GSM623479group B, liver allograft wedge biopsie placebo treatment 6311
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.9812